VIVUS (VVUS) Tops Q1 EPS by 13c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/25/2026

1. RNG
2. DECK
3. WDC
4. BMY
5. BYD
6. SPOT
7. WCN
8. TSCO
9. BE
10. SPY

Go back to VIVUS (VVUS) Tops Q1 EPS by 13c

VIVUS Reports 2017 First Quarter Financial Results

May 3, 2017 4:10 PM EDT

CAMPBELL, CA -- (Marketwired) -- 05/03/17 -- VIVUS,Inc. (NASDAQ: VVUS) (the "Company"), a biopharmaceutical company committed to the development and commercialization of innovative therapies that focus on advancing treatments for patients with serious unmet medical needs, today reported its financial results for the quarter ended March 31, 2017 and provided a business update. Net loss for the 2017 first quarter was $1.1 million, as compared to a net loss of $12.7 million in the first quarter of 2016. Cash, cash equivalents and available-for-sale securities were $260.2 million at March 31, 2017.

"We continue our efforts to reshape VIVUS' business model," said Seth... More